SERINC5

Last updated

Serine incorporator 5 is a protein that in humans is encoded by the SERINC5 gene. [1]

Contents

SERINC5
Identifiers
Aliases SERINC5 , C5orf12, TPO1, serine incorporator 5, chromosome 5 open reading frame 12, AIGP3, C86123, A130038L21Rik
External IDs OMIM: 614551; MGI: 2444223; HomoloGene: 65246; GeneCards: SERINC5; OMA:SERINC5 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001174071
NM_001174072
NM_178276

NM_172588

RefSeq (protein)

NP_001167542
NP_001167543
NP_840060

NP_766176

Location (UCSC) Chr 5: 80.11 – 80.26 Mb Chr 13: 92.75 – 92.85 Mb
PubMed search [4] [5]
Wikidata
View/Edit Human View/Edit Mouse

Properties

SERINC5 is a protein belonging to the serine incorporator (SERINC) family, in the predicted membrane proteins class. [6] It is believed that SERINC5 proteins help incorporate serine into certain lipid bilayer membranes; however, scientists are unsure of their primary function and physiology. [7] [8] Of the five proteins in the human SERINC family, their topologies are strikingly similar. Approximately 17% of amino acids are shared amongst these proteins. [8]

C-terminal Transmembrane Domain

SERINC proteins have about 10 to 11 transmembrane domains. For SERINC5 to localize itself to the plasma membrane to inhibit infectivity by viruses, an extra c-terminal transmembrane domain is required. [7] This extra transmembrane domain allows the protein to express itself stably.

Antagonistic relationships

AP-2 Endocytic Pathway in the presence of Nef. AP-2 Endocytic Pathway with Nef.png
AP-2 Endocytic Pathway in the presence of Nef.
AP-2 Endocytic Pathway in the absence of Nef. AP-2 Endocytic Pathway in the absence of Nef.png
AP-2 Endocytic Pathway in the absence of Nef.

Nef, glycoGag, and S2 viral proteins are located throughout HIV-1 virions that aid in the facilitation of retrovirus release. When present, SERINC5, in the absence of certain virulence factors, prohibits HIV retrovirus particles from fusing to the cell membrane and incorporating their genetic information into target cells. [9] Because SERINC5 is primarily localized via the plasma membrane, and attaches to vesicles carrying virus particles, the restriction factor has the ability to greatly decrease viral infectivity in the early stages of infection. [10] It has been observed in past experiments that the highest SERINC5 concentration, regardless the expression of Nef, decreased infectivity approximately 250-fold. [8] Although poorly understood, it is believed that Nef is a primary cause for the destruction of SERINC5 and other restriction factors. When in the presence of virulence factors, specifically Nef, both SERINC5 and CD4 cells are downregulated through lysosomal degradation via the AP-2 endocytic pathway. [10] This causes rapid infectivity, and an increase in viral load. More recently it was found that SERINC5 mediates a postintegration block to HIV-1 gene expression in Macrophages. [11]

References

  1. "SERINC5 (Gene)". GeneCards. Retrieved April 24, 2019.
  2. 1 2 3 GRCh38: Ensembl release 89: ENSG00000164300 Ensembl, May 2017
  3. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000021703 Ensembl, May 2017
  4. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  6. "SERINC5". The Human Protein Atlas.
  7. 1 2 Zhang, Xianfeng; Zhou, Tao; Yang, Jie; Lin, Yumei; Shi, Jing; Zhang, Xihe; Frabutt, Dylan A.; Zeng, Xiangwei; Li, Sunan (February 2017). Ross, Susan (ed.). "Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction". Journal of Virology. 91 (10): 1–13. doi:10.1128/JVI.00137-17. PMC   5411613 . PMID   28275190 via American Society for Microbiology.
  8. 1 2 3 Rosa, Annachiara; Chande, Ajit; Ziglio, Serena; De Sanctis, Veronica; Bertorelli, Roberto; Goh, Shih Lin; McCauley, Sean M.; Nowosielska, Anetta; Antonarakis, Stylianos E. (October 2015). "HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation". Nature. 526 (7572): 212–217. doi:10.1038/nature15399. PMC   4861059 . PMID   26416734.
  9. Kluge, Silvia F. (October 2015). "SnapShot: Antiviral Restriction Factors" (PDF). Cell. 163 (3): 774–774.e1. doi: 10.1016/j.cell.2015.10.019 . PMID   26496613. S2CID   32924308.
  10. 1 2 Zheng, Yong-Hui; Shi, Jing; Xiong, Ran; Zhou, Tao; Su, Peiyi; Zhang, Xihe; Qiu, Xusheng; Li, Hongmei; Li, Sunan (March 2018). "HIV-1 Nef Antagonizes SERINC5 Restriction by Downregulation of SERINC5 via the Endosome/Lysosome System". Journal of Virology. 92 (11): 16. doi:10.1128/JVI.00196-18. PMC   5952139 . PMID   29514909 via American Society for Microbiology.
  11. Ramdas, Pavitra; Chande, Ajit (2023-03-28). "SERINC5 Mediates a Postintegration Block to HIV-1 Gene Expression in Macrophages". mBio. 14 (2): e00166–23. doi:10.1128/mbio.00166-23. PMC   10127607 . PMID   36976020.